Advanced Asset Management Advisors Inc Eli Lilly & CO Transaction History

Advanced Asset Management Advisors Inc

  • $394 Million
  • Q3 2024

A detailed history of Advanced Asset Management Advisors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Advanced Asset Management Advisors Inc holds 358 shares of LLY stock, worth $284,735. This represents 0.08% of its overall portfolio holdings.

Number of Shares
358
Previous 358 -0.0%
Holding current value
$284,735
Previous $324,000 2.16%
% of portfolio
0.08%
Previous 0.09%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
SELL
$724.87 - $909.04 $31,169 - $39,088
-43 Reduced 10.72%
358 $324,000
Q4 2023

Feb 02, 2024
SELL
$525.19 - $619.13 $154,405 - $182,024
-294 Reduced 42.3%
401 $233,000
Q3 2023

Oct 16, 2023
SELL
$434.7 - $599.3 $10,867 - $14,982
-25 Reduced 3.47%
695 $373,000
Q2 2023

Aug 03, 2023
SELL
$350.74 - $468.98 $1,052 - $1,406
-3 Reduced 0.41%
720 $337,000
Q3 2022

Nov 07, 2022
BUY
$296.48 - $337.87 $8,894 - $10,136
30 Added 4.33%
723 $234,000
Q2 2022

Aug 12, 2022
BUY
$278.73 - $327.27 $193,159 - $226,798
693 New
693 $225,000
Q1 2022

May 04, 2022
SELL
$234.69 - $291.66 $213,567 - $265,410
-910 Closed
0 $0
Q3 2021

Oct 28, 2021
SELL
$221.6 - $272.71 $97,504 - $119,992
-440 Reduced 32.59%
910 $210,000
Q2 2021

Jul 28, 2021
SELL
$180.55 - $233.54 $25,096 - $32,462
-139 Reduced 9.34%
1,350 $310,000
Q1 2021

May 03, 2021
SELL
$164.32 - $212.72 $12,324 - $15,954
-75 Reduced 4.8%
1,489 $278,000
Q4 2020

Feb 08, 2021
BUY
$130.46 - $172.63 $130 - $172
1 Added 0.06%
1,564 $264,000
Q3 2020

Oct 23, 2020
BUY
$146.22 - $169.13 $146 - $169
1 Added 0.06%
1,563 $231,000
Q2 2020

Jul 31, 2020
SELL
$136.42 - $164.18 $68,210 - $82,090
-500 Reduced 24.25%
1,562 $257,000
Q1 2020

May 05, 2020
SELL
$119.05 - $147.35 $7,023 - $8,693
-59 Reduced 2.78%
2,062 $286,000
Q4 2019

Jan 23, 2020
SELL
$106.92 - $132.43 $6,415 - $7,945
-60 Reduced 2.75%
2,121 $279,000
Q3 2019

Oct 29, 2019
BUY
$106.79 - $116.16 $106 - $116
1 Added 0.05%
2,181 $244,000
Q2 2019

Aug 02, 2019
SELL
$110.79 - $129.32 $44,426 - $51,857
-401 Reduced 15.54%
2,180 $242,000
Q1 2019

May 01, 2019
SELL
$111.31 - $131.02 $76,247 - $89,748
-685 Reduced 20.97%
2,581 $335,000
Q4 2018

Feb 04, 2019
BUY
$105.9 - $118.64 $345,869 - $387,478
3,266 New
3,266 $378,000
Q3 2018

Oct 26, 2018
SELL
$85.86 - $107.31 $280,332 - $350,367
-3,265 Closed
0 $0
Q2 2018

Aug 02, 2018
BUY
$75.7 - $86.88 $75 - $86
1 Added 0.03%
3,265 $279,000
Q1 2018

May 04, 2018
BUY
$74.21 - $87.6 $74 - $87
1 Added 0.03%
3,264 $253,000
Q4 2017

Feb 09, 2018
BUY
$81.94 - $87.89 $267,370 - $286,785
3,263
3,263 $276,000

Others Institutions Holding LLY

# of Institutions
4,007
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Advanced Asset Management Advisors Inc Portfolio

Follow Advanced Asset Management Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advanced Asset Management Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Advanced Asset Management Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email